Fig. 2From: Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real worldPerformance analysis of SARS-CoV-2 NTAb. Linearity assessment of NTAb assays (A). Correlation between the CLIA results and PRNT50 titers serum antibodies in vaccine recipients (B, C)Back to article page